Kilitch Drugs (India) Limited · KILITCH
Every Kilitch Drugs (India) Limited result whose ten-session window has closed, judged against the last read made before it. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →
24results judged
0read right
0read wrong
0flat / no call
24unread
13%beat the market
-5.4%avg vs market, 10d
5.4%avg move, T+1
How the reads on it fared
| Read | Judged | Right | Wrong | Flat | Hit rate | Avg vs mkt | |
|---|---|---|---|---|---|---|---|
| unread | 24 | 0 | 0 | 0 | — | -5.4% |
A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.
Reading the rows
- T+1
- the share's move on the first session after the result, from the close before it
- T+10
- the move over ten sessions, same base
- vs market
- T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
- Run-up
- the share's move in the thirty sessions before the result
- Result
- reported profit growth against the company's own last four quarters: good, in line, bad
Each result
24 judged · newest first · open one| Result | Read | Outcome | T+1 | T+10 | vs market | Run-up | Result | Why | |
|---|---|---|---|---|---|---|---|---|---|
| 13 Aug Q1FY27 | — | unread | -9.7% | -10.2% | -9.3% | -3% | no figures |
|
› |
| 15 May Q4FY26 | — | unread | +13.5% | +17.8% | +18.9% | — | no figures |
|
› |
| 11 Feb Q3FY26 | — | unread | -10.7% | -12.3% | -10.6% | +6% | no figures |
|
› |
| 13 Nov Q2FY26 | — | unread | -3.1% | -6.9% | -8.2% | +9% | no figures |
|
› |
| 13 Aug Q1FY26 | — | unread | -4.0% | -18.2% | -18.2% | -2% | no figures |
|
› |
| 19 May Q4FY25 | — | unread | +7.3% | -3.9% | -2.2% | +22% | no figures |
|
› |
| 11 Feb Q3FY25 | — | unread | -1.0% | -1.6% | +0.7% | -2% | no figures |
|
› |
| 12 Nov Q2FY25 | — | unread | +11.1% | +3.3% | +3.1% | -12% | no figures |
|
› |
| 8 Aug Q1FY25 | — | unread | -3.3% | -1.5% | -5.2% | +0% | no figures |
|
› |
| 28 May Q4FY24 | — | unread | -0.3% | -4.4% | -6.3% | -5% | no figures |
|
› |
| 8 Feb Q3FY24 | — | unread | -9.8% | -12.1% | -14.3% | +25% | no figures |
|
› |
| 10 Nov Q2FY24 | — | unread | -0.0% | +0.0% | -3.4% | +30% | no figures |
|
› |
| 30 May Q4FY23 | — | unread | -8.0% | -5.5% | -5.5% | +27% | no figures |
|
› |
| 15 Feb Q3FY23 | — | unread | -1.3% | -5.7% | -3.1% | -7% | no figures |
|
› |
| 15 Nov Q2FY23 | — | unread | -3.7% | -8.9% | -10.5% | +6% | no figures |
|
› |
| 11 Aug Q1FY23 | — | unread | +5.7% | +0.5% | +0.4% | +0% | no figures |
|
› |
| 27 May Q4FY22 | — | unread | +8.4% | +1.4% | +4.9% | -26% | no figures |
|
› |
| 15 Feb Q3FY22 | — | unread | -9.7% | -17.1% | -15.7% | — | no figures |
|
› |
| 12 Nov Q2FY22 | — | unread | +0.4% | -9.6% | -3.4% | +2% | no figures |
|
› |
| 13 Aug Q1FY22 | — | unread | -6.0% | -13.0% | -16.7% | +28% | no figures |
|
› |
| 23 Jun Q4FY21 | — | unread | +3.4% | -3.2% | -3.4% | +7% | no figures |
|
› |
| 12 Feb Q3FY21 | — | unread | -1.1% | -5.2% | -1.0% | -3% | no figures |
|
› |
| 16 Sep Q1FY21 | — | unread | -2.4% | -10.2% | -8.6% | +6% | no figures |
|
› |
| 1 Jul Q4FY20 | — | unread | -5.8% | -9.4% | -12.4% | +11% | no figures |
|
› |